Manager II
BioAgilytix
Durham, North Carolina
Liz Nolff, MS, Manager II, has 20+ years of assay development and validation experience with various modalities and therapies (cell and gene therapy, enzyme replacement, monoclonal antibodies, and lipid and hormone small molecule ligand binding assays). Nolff serves as Manager II, BPM at BioAgilytix, servicing a strong client portfolio specializing in Immunogenicity, PK, Oligo Hybridization LBA, and Biomarker studies. She previously worked for Enzo Life Sciences (NY, USA) and Cayman Chemical (MI, USA), identifying emerging areas of research, diagnostics, and drug discovery, and implementing products of interest to various disciplines into these pipelines. She earned her BSc from Michigan State University (MI, USA) and her MSc from Johns Hopkins University (MD, USA)
Disclosure information not submitted.
Comparison of Two Hybridization LBA Platforms for Oligonucleotide Therapeutic Quantification
Wednesday, November 12, 2025
10:00 AM - 10:30 AM CT